Dov Goldstein, M.D.

Dov Goldstein, M.D.

DirectoratGain Therapeutics· In proxies 2023–2025

Dov Goldstein, M.D. sits on 5 public boards.

Boards1

  • Gain TherapeuticsDirector · 4 yr on the boardIndependentAudit (Chair), Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Gain TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -60%
  2. Coya Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. NeuBase TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  4. Durata TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  5. Esperion TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?